Stryker (NYSE:SYK), a global leader in medical technologies, announced the launch of the ProCeed hospital bed, offering ...

Medical technology company Stryker (NYSE:SYK) reported in Q4 CY2024, with sales up 10.7% year on year to $6.44 billion. Its non-GAAP profit of $4.01 per share was 3.5% above analysts’ consensus ...

Notably, Stryker was named the most admired medtech company in the world. Another major orthopedic and spine device manufacturer, Medtronic, also earned a spot. 1. Stryker Corp.

Stryker is gaining momentum with strong Q4 results, innovative medtech solutions and high-growth market expansion. But, is ...

Stryker Corporation (NYSE:SYK), a leading player in the medical technology industry with a substantial market capitalization of $149 billion, has been making waves with its strong financial ...

Stryker’s US spinal implants sale to VB Spine creates growth opportunities for competitors like Medtronic and Globus in the ...

Portage, Michigan, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in Citi’s 2025 Unplugged Medtech and Life Sciences Access Day on Thursday, February 27, 2025 at Citigroup ...

Medical technology company Stryker plans to sell its U.S. spinal implants business to investment firm Viscogliosi Brothers for an undisclosed amount, the company announced Tuesday. The deal is ...

From FDA approvals to medical milestones, here are four key developments from spine and orthopedic medtech companies since Jan. 29.